Cargando…
IRAP Inhibitors: M1-Aminopeptidase Family Inspiration
The insulin regulated aminopeptidase (IRAP) has been proposed as an important therapeutic target for indications including Alzheimer’s disease and immune disorders. To date, a number of IRAP inhibitor designs have been investigated but the total number of molecules investigated remains quite small....
Autores principales: | Barlow, Nicholas, Thompson, Philip E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546331/ https://www.ncbi.nlm.nih.gov/pubmed/33101040 http://dx.doi.org/10.3389/fphar.2020.585930 |
Ejemplares similares
-
The Discovery of Insulin-Regulated Aminopeptidase (IRAP) Inhibitors: A Literature Review
por: Georgiadis, Dimitris, et al.
Publicado: (2020) -
Inhibition of Insulin-Regulated Aminopeptidase (IRAP) by Arylsulfonamides
por: Borhade, Sanjay R, et al.
Publicado: (2014) -
Structural Basis of Inhibition of Human Insulin-Regulated Aminopeptidase (IRAP) by Benzopyran-Based Inhibitors
por: Vanga, Sudarsana Reddy, et al.
Publicado: (2021) -
S-acylation of the Insulin-Responsive Aminopeptidase (IRAP): Quantitative analysis and Identification of Modified Cysteines
por: Werno, Martin W., et al.
Publicado: (2015) -
Structural Basis of Inhibition of Human Insulin-Regulated
Aminopeptidase (IRAP) by Aryl Sulfonamides
por: Vanga, Sudarsana Reddy, et al.
Publicado: (2018)